Aspire Biopharma Inc.

ASBP | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.23

-$0.49 (-5.62%)

Sep 22, 2026, 12:26 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-5.62%

(1D)

Rating

Updated: Aug 25, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $949.89K

1D Range

8.15 8.84

52W Range

0.11 18.76

Valuation (TTM)

PE -1.09

PB 0.09

EV/EBITDA -3.65

Valuation (NTM)

Forward PE N/A

Forward PEG -0.01

Price Target N/A

Cash Flow

FCF Yield -714.3%

SBC Adj. FCF Yield -729.9%

SBC Impact -2.2%

Margins

Gross Margin 18.4%

Operating Margin -7494.8%

FCF Margin -7358.1%

Growth (CAGR)

Revenue 3Y | 5Y 150.0% | 100.0%

Dil EPS 3Y | 5Y -10.7% | -79.7%

FCF 3Y | 5Y -47.8% | -47.1%

Returns

ROA -81.6%

ROE 1993.3%

ROIC -59.8%

Financial Health

Net Cash

$12.17M

Current Ratio 7.99

Interest Coverage -0.76

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship ...

Sector Healthcare

Industry Biotechnology

Employees 2

IPO Date Feb 19, 2025

Website aspirebiolabs.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.